FinscoFinsco

Core Scientific (US.CORZ)

Capital Allocation Audit · Period: 2019 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.CORZ · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion-313.2%↓
ROE-→
Cash Conversion-→
D/E Ratio-→
Gross Margin35.8%↑
US.CORZ (Core Scientific) | YoY: 2026 H1 vs 2025 H1


Metric             Value  YoY
-----------------------------
FCF Conversion   -313.2%    ↓
ROE                    -    →
Cash Conversion        -    →
D/E Ratio              -    →
Gross Margin       35.8%    ↑
Key Metrics
US.CORZ (Core Scientific) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
-----------------------------
FCF Conversion -313.2% ↓
ROE - →
Cash Conversion - →
D/E Ratio - →
Gross Margin 35.8% ↑

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies